Skip to main content
. 2022 Jul;23(7):2351–2359. doi: 10.31557/APJCP.2022.23.7.2351

Table 1.

Pathological Profile and Protein Expression (ER, PR, HER2, TP53, Ki67, CK5/6 and CK8/18) in EBV Positive (EBER1) Cases (n= 5)

In situ hibridization Immunohistochemistry Histopathology
ER PR HER2 TP53 Ki67 CK5/6 CK8/18
Age R S R LI R LI R E R LI R LI R R G S. Tumor
55 + F + 60 + 20 - - - 0 + 99 - + III T2
45 + F + 5 - 0 - - + 80 + 8 - + I T2
64 + F + 40 - 0 - + - 0 + 35 - + I T1
54 + F + 80 + 40 - + - 0 + 20 - + III T1
47 + F + 80 + 80 + +++ + 95 + 25 - + III T3

ER, estrogen receptor; PR, progesterone receptor; HER2, epidermal growth factor receptor 2; CK, cytokeratin; R, result; S, staining; F, focal;

LI, labelling index (%); E, score; G, grade; S, tumor: tumor size.